UNI-EN 114:Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 114 | / | 2020 | |||||||
| Date of issue: | 2020-09-28 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, September 28, 2020 – In accordance with the requirements of art. 100t of LPOS “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that at the Extraordinary General Meeting of Shareholders of “Sopharma” AD, held on September 25, 2020 at 11:00 a.m. (UTC 8:00 a.m.), with a majority of 97.61% of the represented capital, in accordance with § 20 of The transitional and final provisions of Ordinance no. 48 of March 20, 2013 of the Financial Supervision Commission /promulgated, SG, no. 32 of 2.04.2013, amended and supplemented, no. 41 of 21.05.2019, amended, no. 66 of 20.08.2019, amended and supplemented, no. 61 of 10.07.2020/ a new Policy for formation of the remuneration of the members of the Board of Directors of „Sopharma“ AD was adopted. The Current Policy is available on the Company's website: https://www.sopharmagroup.com/sites/sopharma2016corp/files/3jr_remuneration_policy_2020_en_1.pdf | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Remuneration Policy Notification.rar Remuneration Policy Notification.rar | Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-09-28 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 17.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
